# Brogent China Life Sciences Ltd. — Form D

Brogent China Life Sciences Ltd. of GRAND CAYMAN, E9, a company, filed a Form D exempt-offering notice with the SEC on 2019-02-05. The offering totals $10.0M, of which $1.5M was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2019-02-05
- Form: D
- Accession: 0001766809-19-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $1.5M
- Remaining: $8.5M
- Minimum investment: $250K
- Investors: 2
- Date of first sale: 2019-01-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-332133

## Issuer

- Name: Brogent China Life Sciences Ltd.
- CIK: 0001766809
- Entity type: Other
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2018
- Address: C/O Maples & Calder, GRAND CAYMAN, E9, KY1-1104
- Phone: 6466942516

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Andrew John Economos | Director | New York, NY |
| Peter John Gruber | Director | New York, NY |
| Stephen Bernard Gruber | Director | New York, NY |
| Paul Louis Scibetta | Director | New York, NY |

## More

- [CIK 1766809 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1766809&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001766809-19-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.